Effects of ezetimibe/simvastatin compared to simvastatin monotherapy in reducing C-reactive protein and low density lipoprotein-cholesterol

被引：0
|
作者：
Ballantyne, CM
Ridker, P
Pearson, T
Veltri, E
Mitchel, YB
Sisk, CMM
Shah, AK
Maccubbin, DL
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2006年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：316A / 316A
页数：1
相关论文
共 50 条
  • [31] IMPACT OF SWITCHING TO SIMVASTATIN ON LOW DENSITY LIPOPROTEIN CHOLESTEROL GOAL ATTAINMENT
    Tunceli, K.
    Sajjan, S.
    Ramey, D.
    Neff, D.
    Tershakovec, A.
    Hu, H.
    Foody, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 118 - 119
  • [32] Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction
    Toth, Peter P.
    Ballantyne, Christie M.
    Davidson, Michael H.
    Tomassini, Joanne E.
    Ramey, Dena Rosen
    Neff, David
    Tershakovec, Andrew M.
    Hu, X. Henry
    Tunceli, Kaan
    JOURNAL OF CLINICAL LIPIDOLOGY, 2012, 6 (02) : 180 - 191
  • [33] Simvastatin and Ezetimibe in addition to nonpharmacological risk factor modification for achieving new low-density lipoprotein cholesterol targets
    Liska, Branislav
    Khattab, Ahmed A.
    Herrmann, Lutz
    Abdel-Wahab, Mohamed
    Westphal, Ronja
    Toelg, Ralph
    Geist, Volker
    Richardt, Gert
    HERZ, 2008, 33 (05) : 362 - 367
  • [34] Binding of C-reactive protein to modified low-density-lipoprotein particles:: identification of cholesterol as a novel ligand for C-reactive protein
    Taskinen, S
    Kovanen, PT
    Jarva, H
    Meri, S
    Pentikäinen, MO
    BIOCHEMICAL JOURNAL, 2002, 367 : 403 - 412
  • [35] Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)
    Robinson, Jennifer G.
    Ballantyne, Christie M.
    Hsueh, Willa
    Rosen, Jeffrey
    Lin, Jianxin
    Shah, Arvind
    Lowe, Robert S.
    Hanson, Mary E.
    Tershakovec, Andrew M.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (06) : 474 - 482
  • [36] Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia
    Li, JJ
    Chen, MZ
    Chen, X
    Fang, CH
    CLINICAL CARDIOLOGY, 2003, 26 (10) : 472 - 476
  • [37] Combination Therapy With Ezetimibe/Simvastatin Versus Statin Monotherapy for Low-Density Lipoprotein Cholesterol Reduction and Goal Attainment in a Real-World Clinical Setting
    Friedman, Howard S.
    Rajagopalan, Srinivasan
    Barnes, Jaime P.
    Roseman, Hal
    CLINICAL THERAPEUTICS, 2011, 33 (02) : 212 - 224
  • [38] Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT"
    Bohula, Erin A.
    Giugliano, Robert P.
    Cannon, Christopher P.
    Zhou, Jing
    Murphy, Sabina A.
    White, Jennifer
    Tershakovec, Andrew M.
    Blazing, Michael A.
    Braunwald, Eugene
    CIRCULATION, 2016, 133 (13) : E463 - E463
  • [39] Comparison of Ezetimibe/Simvastatin 10/20 mg Versus Atorvastatin 20 mg in Achieving a Target Low Density Lipoprotein-Cholesterol Goal for Patients With Very High Risk
    Cho, Yun-Kyeong
    Hur, Seung-Ho
    Han, Chun-Duk
    Park, Hyoung-Seob
    Yoon, Hyuck-Jun
    Kim, Hyungseop
    Nam, Chang-Wook
    Kim, Yoon-Nyun
    Kim, Kwon-Bae
    Park, Nam-Hee
    Park, Hee-Jun
    KOREAN CIRCULATION JOURNAL, 2011, 41 (03) : 149 - 153
  • [40] Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial
    Hirsch, M
    O'Donnel, JC
    Jones, P
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2005, 12 (01): : 18 - 28
12345